
205. SERDs Explained: What’s New in Breast Cancer Treatment with Dr. Sara Nunnery
On this episode of the Interlude Podcast, I am joined by breast medical oncologist, Dr. Sara Nunnery, to break down one of the most exciting and rapidly evolving areas of breast cancer treatment: selective estrogen receptor degraders (SERDs). We discuss how SERDs work, why ESR1 mutations matter, and how newer endocrine therapies are changing the treatment landscape for hormone receptor-positive breast cancer. From recent FDA approvals and a new approach to detecting treatment resistance before cancer progresses to promising research in early-stage breast cancer, we explore what these advances mean for patients, how treatment decisions are made, and what questions still need answers.
Publisher
INTERLUDE: Cancer Stories with Dr. Teplinsky
Link
interludecancerstories.com/2026/11/07/205-serds-explained-whats-new-in-breast-cancer-treatment-with-dr-sara-nunnery/
Published
November 7, 2026
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
Eleonora Teplinsky
INTERLUDE: Cancer Stories with Dr. Teplinsky
@interludecancerstorieswithdr
#serdsexplained #breastcancertreatment #saranunnery #medicine
